These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8229340)

  • 21. Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine.
    Tsuda H; Miyata Y; Murasaki G; Kinoshita H; Fukushima S
    Gan; 1977 Apr; 68(2):183-92. PubMed ID: 892292
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of case-control studies in the general population and in occupational cohorts to study genetic susceptibility and cancer risk.
    Rothman N
    Med Lav; 1995; 86(3):221-5. PubMed ID: 7565281
    [No Abstract]   [Full Text] [Related]  

  • 23. Occupational and nonoccupational causes of bladder cancer.
    Golka K
    South Med J; 2006 Nov; 99(11):1203. PubMed ID: 17195410
    [No Abstract]   [Full Text] [Related]  

  • 24. Bladder cancer and occupational exposure to metalworking fluid mist: a counter-matched case-control study in French steel-producing factories.
    Colin R; Grzebyk M; Wild P; Hédelin G; Bourgkard È
    Occup Environ Med; 2018 May; 75(5):328-336. PubMed ID: 29374095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exposure to occupational carcinogens and social class differences in cancer occurrence.
    Boffetta P; Kogevinas M; Westerholm P; Saracci R
    IARC Sci Publ; 1997; (138):331-41. PubMed ID: 9353674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Industrial experience with 3,3'-dichlorobenzidine: an epidemiological study of a chemical manufacturing plant.
    Gerarde HW; Gerarde DF
    J Occup Med; 1974 May; 16(5):322-35. PubMed ID: 4826347
    [No Abstract]   [Full Text] [Related]  

  • 27. Editorial comment.
    Landrigan PJ
    J Urol; 2013 Jan; 189(1):52. PubMed ID: 23164374
    [No Abstract]   [Full Text] [Related]  

  • 28. Bladder cancer incidence and exposure to polycyclic aromatic hydrocarbons among asphalt pavers.
    Burstyn I; Kromhout H; Johansen C; Langard S; Kauppinen T; Shaham J; Ferro G; Boffetta P
    Occup Environ Med; 2007 Aug; 64(8):520-6. PubMed ID: 17332134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Occupational bladder tumors among persons subjected to carcinogenic amino compound exposure: the epidemiology and prevention].
    Bul'bulian MA
    Urol Nefrol (Mosk); 1991; (4):12-8. PubMed ID: 1949409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exposed workers and bladder cancer in Italy: an estimate starting from the ISPESL's database of enterprises.
    Scarselli A; Scano P; Marinaccio A
    Ind Health; 2009 Dec; 47(6):673-6. PubMed ID: 19996544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of occupational exposures in nonmuscle infiltration bladder cancer: preliminary results of a prospective study from October 2005 to February 2009].
    Pecoux F; Fantoni JC; Berthon N; Lepage N; Sobaszek A; Sebbane N; Devos P; Biserte J
    Prog Urol; 2011 Jun; 21(6):405-11. PubMed ID: 21620301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of occupational tumours of the bladder.
    Davies JM
    Proc R Soc Med; 1966 Dec; 59(12):1247-8. PubMed ID: 5955212
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of Occupational Exposures and Genetic Polymorphisms on Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer.
    Carta A; Pavanello S; Mastrangelo G; Fedeli U; Arici C; Porru S
    Int J Environ Res Public Health; 2018 Jul; 15(8):. PubMed ID: 30042310
    [No Abstract]   [Full Text] [Related]  

  • 34. 3,3'-Dichlorobenzidine and its dihydrochloride.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1982 May; 29():238-56. PubMed ID: 6751990
    [No Abstract]   [Full Text] [Related]  

  • 35. Epidemiology of cancer from exposure to arylamines.
    Vineis P
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):7-10. PubMed ID: 7889862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms of 3,3'-dichlorobenzidine-mediated toxicity in HepG2 cells.
    Chen LC; Wu JC; Tuan YF; Tseng YK; Hseu YC; Chen SC
    Environ Mol Mutagen; 2014 Jun; 55(5):407-20. PubMed ID: 24604609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occupational exposure to solvents and bladder cancer: A population-based case control study in Nordic countries.
    Hadkhale K; Martinsen JI; Weiderpass E; Kjaerheim K; Sparen P; Tryggvadottir L; Lynge E; Pukkala E
    Int J Cancer; 2017 Apr; 140(8):1736-1746. PubMed ID: 28032642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RE: Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms.
    Selinski S; Krech E; Ovsiannikov D; Blaszkewicz M; Hengstler JG; Golka K
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26857137
    [No Abstract]   [Full Text] [Related]  

  • 39. An epidemic of bladder cancer: ten cases of bladder cancer in male Japanese workers exposed to ortho-toluidine.
    Nakano M; Omae K; Takebayashi T; Tanaka S; Koda S
    J Occup Health; 2018 Jul; 60(4):307-311. PubMed ID: 29743389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response.
    Figueroa JD; Prokunina-Olsson L; Koutros S; Garcia-Closas M; Chanock S; Silverman DT; Rothman N
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26857138
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.